{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:47:30Z","timestamp":1787028450300,"version":"build-2736575974"},"reference-count":330,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T00:00:00Z","timestamp":1618012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","award":["IT10214"],"award-info":[{"award-number":["IT10214"]}],"id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CUPFA","award":["Professional Development Award"],"award-info":[{"award-number":["Professional Development Award"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Renal cell carcinoma (RCC) and autosomal dominant polycystic kidney disease (ADPKD) share several characteristics, including neoplastic cell growth, kidney cysts, and limited therapeutics. As well, both exhibit impaired vasculature and compensatory VEGF activation of angiogenesis. The PI3K\/AKT\/mTOR and Ras\/Raf\/ERK pathways play important roles in regulating cystic and tumor cell proliferation and growth. Both RCC and ADPKD result in hypoxia, where HIF-\u03b1 signaling is activated in response to oxygen deprivation. Primary cilia and altered cell metabolism may play a role in disease progression. Non-coding RNAs may regulate RCC carcinogenesis and ADPKD through their varied effects. Drosophila exhibits remarkable conservation of the pathways involved in RCC and ADPKD. Here, we review the progress towards understanding disease mechanisms, partially overlapping cellular and molecular dysfunctions in RCC and ADPKD and reflect on the potential for the agile Drosophila genetic model to accelerate discovery science, address unresolved mechanistic aspects of these diseases, and perform rapid pharmacological screens.<\/jats:p>","DOI":"10.3390\/ijms22083918","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T03:04:06Z","timestamp":1618196646000},"page":"3918","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Modeling Neoplastic Growth in Renal Cell Carcinoma and Polycystic Kidney Disease"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1521-0778","authenticated-orcid":false,"given":"Cassandra","family":"Millet-Boureima","sequence":"first","affiliation":[{"name":"Department of Biology, Concordia University, Montreal, QC H4B 1R6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"He","sequence":"additional","affiliation":[{"name":"Department of Biology, Concordia University, Montreal, QC H4B 1R6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Bich Uyen","family":"Le","sequence":"additional","affiliation":[{"name":"Department of Biology, Concordia University, Montreal, QC H4B 1R6, Canada"},{"name":"Haematology-Oncology Research Group, National University Cancer Institute, Singapore 119228, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7122-6491","authenticated-orcid":false,"given":"Chiara","family":"Gamberi","sequence":"additional","affiliation":[{"name":"Department of Biology, Coastal Carolina University, Conway, SC 29528-6054, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,10]]},"reference":[{"key":"ref_1","first-page":"1000165","article-title":"Genomic instability and cancer","volume":"5","author":"Yao","year":"2014","journal-title":"J. Carcinog. Mutagen."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrurol.2010.46","article-title":"Epidemiology and risk factors for kidney cancer","volume":"7","author":"Chow","year":"2010","journal-title":"Nat. Rev. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2014.10.002","article-title":"International variations and trends in renal cell carcinoma incidence and mortality","volume":"67","author":"Znaor","year":"2015","journal-title":"Eur. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.eururo.2011.06.049","article-title":"The epidemiology of renal cell carcinoma","volume":"60","author":"Ljunberg","year":"2011","journal-title":"Eur. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_6","unstructured":"Amiji, M.M., and Ramesh, R. (2018). Diagnostic and Therapeutic Applications of Exosomes in Cancer, Elsevier. [1st ed.]."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"Cancer J. Clin."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur. Urol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs\u2014Part A: Renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/cncr.30314","article-title":"Renal cancer subtypes: Should we be lumping or splitting for therapeutic decision making?","volume":"123","author":"Haake","year":"2017","journal-title":"Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1038\/s41388-020-1234-3","article-title":"Modeling clear cell renal cell carcinoma and therapeutic implications","volume":"39","author":"Wolf","year":"2020","journal-title":"Oncogene"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1590\/0100-3984.2013.1927","article-title":"Renal cell carcinoma: Histological classification and correlation with imaging findings","volume":"48","author":"Muglia","year":"2015","journal-title":"Radiol. Bras."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G","article-title":"The Heidelberg classification of renal cell tumours","volume":"183","author":"Kovacs","year":"1997","journal-title":"J. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/01.ju.0000096060.92397.ed","article-title":"The genetic basis of cancer of the kidney","volume":"170","author":"Linehan","year":"2003","journal-title":"J. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MOU.0000000000000307","article-title":"Molecular profiling of renal cell carcinoma: Building a bridge towards clinical impact","volume":"26","author":"Manley","year":"2016","journal-title":"Curr. Opin. Urol."},{"key":"ref_16","first-page":"379","article-title":"The skeletal metastatic complications of renal cell carcinoma","volume":"19","author":"Zekri","year":"2001","journal-title":"Int. J. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Janzen, N.K., Perry, K.T., and Schulam, P.G. (2003). Laparoscopic radical nephrectomy and minimally invasive surgery for kidney cancer. Kidney Cancer, 99\u2013117.","DOI":"10.1007\/978-1-4615-0451-1_6"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.critrevonc.2007.08.003","article-title":"Prognostic factors and selection for clinical studies of patients with kidney cancer","volume":"65","author":"Lam","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"15766","DOI":"10.18632\/oncotarget.24607","article-title":"Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinoma","volume":"9","author":"Frees","year":"2018","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.humpath.2014.02.004","article-title":"Papillary renal cell carcinoma revisited: A comprehensive histomorphologic study with outcome correlations","volume":"45","author":"Warrick","year":"2014","journal-title":"Hum. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng.3146","article-title":"Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes","volume":"47","author":"Durinck","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_22","first-page":"537","article-title":"Papillary renal cell carcinoma: A clinicopathologic and immunohistochemical study of 105 tumors","volume":"10","author":"Delahunt","year":"1997","journal-title":"Mod. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eururo.2014.04.029","article-title":"Understanding pathologic variants of renal cell carcinoma: Distilling therapeutic opportunities from biologic complexity","volume":"67","author":"Shuch","year":"2015","journal-title":"Eur. Urol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/jclinpath-2018-205211","article-title":"A family case with germline TSC1 and mtDNA mutations developing bilateral eosinophilic chromophobe renal cell carcinomas without other typical phenotype of tuberous sclerosis","volume":"71","author":"Sakamoto","year":"2018","journal-title":"J. Clin. Pathol."},{"key":"ref_25","first-page":"1767","article-title":"Identification of CFTR as a novel key gene in chromophobe renal cell carcinoma through bioinformatics analysis","volume":"18","author":"Wang","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/0974-7796.110012","article-title":"Multilocular cystic renal cell carcinoma a diagnostic dilemma: A case report in a 30-year-old woman","volume":"5","author":"Chowdhury","year":"2013","journal-title":"Urol. Ann."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4111\/icu.2019.60.3.148","article-title":"SETD2, GIGYF2, FGFR3, BCR, KMT2C, and TSC2 as candidate genes for differentiating multilocular cystic renal neoplasm of low malignant potential from clear cell renal cell carcinoma with cystic change","volume":"60","author":"Kim","year":"2019","journal-title":"Investig. Clin. Urol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"29901","DOI":"10.18632\/oncotarget.9093","article-title":"Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ejhg.2010.175","article-title":"Von Hippel-Lindau disease: A clinical and scientific review","volume":"19","author":"Maher","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_30","first-page":"429","article-title":"Epidemiological features of Wilms\u2019 tumor: Results of the National Wilms\u2019 Tumor Study","volume":"68","author":"Breslow","year":"1982","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S2352-4642(19)30064-1","article-title":"Identifying new Wilms tumour predisposition genes","volume":"3","author":"Weksberg","year":"2019","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_32","unstructured":"Gladell, P., and Paner, M.D. (2021, February 25). Clear Cell Renal Carcinoma: Fuhrman Nuclear Grade. Available online: https:\/\/www.auanet.org\/education\/auauniversity\/education-products-and-resources\/pathology-for-urologists\/kidney\/renal-cell-carcinomas\/clear-cell-renal-cell-carcinoma-fuhrman-nuclear-grade."},{"key":"ref_33","unstructured":"Williamson, S.R. (2021, January 21). Grading. Available online: https:\/\/www.pathologyoutlines.com\/topic\/kidneytumormalignantnucleargrading.html."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Sparapani, S., Millet-Boureima, C., Oliver, J., Mu, K., Hadavi, P., Kalostian, T., Ali, N., Avelar, C.M., Bardies, M., and Barrow, B. (2021). The biology of vasopressin. Biomedicines, 9.","DOI":"10.3390\/biomedicines9010089"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","article-title":"Polycystic kidney disease","volume":"60","author":"Harris","year":"2009","journal-title":"Annu. Rev. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.1523-1755.2005.00201.x","article-title":"Molecular pathogenesis of ADPKD: The polycystin complex gets complex","volume":"67","author":"Ong","year":"2005","journal-title":"Kidney Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/ki.1997.3","article-title":"Renal cysts, renal cancer and von Hippel-Lindau disease","volume":"51","author":"Neumann","year":"1997","journal-title":"Kidney Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.2215\/CJN.02020309","article-title":"Renal cystic diseases and renal neoplasms: A mini-review","volume":"4","author":"Bonsib","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Chen, S., Jin, B., Xu, L., Fu, G., Meng, H., Liu, B., Li, J., and Xia, D. (2014). Cystic renal cell carcinoma: A report of 67 cases including 4 cases with concurrent renal cell carcinoma. BMC Urol., 14.","DOI":"10.1186\/1471-2490-14-87"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1477-7819-11-158","article-title":"Diagnosis and treatment of cystic renal cell carcinoma","volume":"11","author":"Zhang","year":"2013","journal-title":"World J. Surg. Oncol."},{"key":"ref_42","first-page":"1","article-title":"Development of acquired cystic disease and adenocarcinoma of the kidney in glomerulonephritic chronic hemodialysis patients","volume":"14","author":"Ishikawa","year":"1980","journal-title":"Clin. Nephrol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0272-6386(12)80507-5","article-title":"Polycystic kidney disease: Neoplasia in disguise","volume":"15","author":"Grantham","year":"1990","journal-title":"Am. J. Kidney Dis."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"de Werra, C., Donzelli, I., Perone, M., Micco, R.D., and Orabona, G. (2009). Multifocal and multicentric tumors. Multiple Primary Malignancies. Updates in Surgery, Springer.","DOI":"10.1007\/978-88-470-1095-6_9"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.celrep.2017.02.074","article-title":"The SWI\/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma","volume":"18","author":"Nargund","year":"2017","journal-title":"Cell Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1537709","DOI":"10.1080\/23723556.2018.1537709","article-title":"MTORC1-driven accumulation of the oncometabolite fumarate as a potential critical step in renal cancer progression","volume":"6","author":"Drusian","year":"2019","journal-title":"Mol. Cell. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/01.ASN.0000016444.90348.50","article-title":"Epithelial-specific Cre\/lox recombination in the developing kidney and genitourinary tract","volume":"13","author":"Shao","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1535-6108(02)00071-5","article-title":"HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron","volume":"1","author":"Mandriota","year":"2002","journal-title":"Cancer Cell"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"109624","DOI":"10.1016\/j.cellsig.2020.109624","article-title":"Endothelial-epithelial communication in polycystic kidney disease: Role of vascular endothelial growth factor signalling","volume":"72","author":"Jafree","year":"2020","journal-title":"Cell. Signal."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"P353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/s-0030-1253454","article-title":"Heterogeneity of the tumor vasculature","volume":"36","author":"Nagy","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ajh.21745","article-title":"Pericytes and vessel maturation during tumor angiogenesis and metastasis","volume":"85","author":"Raza","year":"2010","journal-title":"Am. J. Hematol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00467-012-2305-7","article-title":"Angiogenesis and autosomal dominant polycystic kidney disease","volume":"28","author":"Huang","year":"2013","journal-title":"Pediatr. Nephrol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1523-1755.2001.00768.x","article-title":"Angiogenesis in autosomal-dominant polycystic kidney disease","volume":"60","author":"Holubec","year":"2001","journal-title":"Kidney. Int."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/sj.ki.5001725","article-title":"Evidence of angiogenesis and microvascular regression in autosomal-dominant polycystic kidney disease kidneys: A corrosion cast study","volume":"70","author":"Wei","year":"2006","journal-title":"Kidney Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1681\/ASN.2014090856","article-title":"Vascular endothelial growth factor C for polycystic kidney diseases","volume":"27","author":"Huang","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"F1145","DOI":"10.1152\/ajprenal.00337.2017","article-title":"In vivo three-dimensional photoacoustic imaging of the renal vasculature in preclinical rodent models","volume":"314","author":"Ogunlade","year":"2018","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nm.2545","article-title":"The lymphatic vasculature in disease","volume":"17","author":"Alitalo","year":"2011","journal-title":"Nat. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.celrep.2014.03.064","article-title":"Polycystin signaling is required for directed endothelial cell migration and lymphatic development","volume":"7","author":"Outeda","year":"2014","journal-title":"Cell Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e48183","DOI":"10.7554\/eLife.48183","article-title":"Spatiotemporal dynamics and heterogeneity of renal lymphatics in mammalian development and cystic kidney disease","volume":"8","author":"Jafree","year":"2019","journal-title":"eLife"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000088478","article-title":"VEGF as a key mediator of angiogenesis in cancer","volume":"69","author":"Carmeliet","year":"2005","journal-title":"Oncology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1681\/ASN.2014010060","article-title":"Tubulovascular cross-talk by vascular endothelial growth factor a maintains peritubular microvasculature in kidney","volume":"26","author":"Dimke","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","article-title":"Systems biology of autosomal dominant polycystic kidney disease (ADPKD): Computational identification of gene expression pathways and integrated regulatory networks","volume":"18","author":"Song","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejrad.2007.01.033","article-title":"Assessment of the kidney tumor vascular supply by 2-phase MDCT-angiography","volume":"62","author":"Ferda","year":"2007","journal-title":"Eur. J. Radiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/cncr.24238","article-title":"Complexity of tumor vasculature in clear cell renal cell carcinoma","volume":"115","author":"Qian","year":"2009","journal-title":"Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.bjc.6601105","article-title":"Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxane","volume":"89","author":"Anderson","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41379-019-0214-z","article-title":"Specific immune cell and lymphatic vessel signatures identified by image analysis in renal cancer","volume":"32","author":"Schraml","year":"2019","journal-title":"Mod. Pathol."},{"key":"ref_68","first-page":"27","article-title":"Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma","volume":"56","author":"Moch","year":"1996","journal-title":"Cancer Res."},{"key":"ref_69","first-page":"481","article-title":"Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: Importance of 1q and 3p copy number changes in metastatic events","volume":"57","author":"Gronwald","year":"1997","journal-title":"Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1096-9896(199710)183:2<151::AID-PATH928>3.0.CO;2-R","article-title":"Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas","volume":"183","author":"Schullerus","year":"1997","journal-title":"J. Pathol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000056987","article-title":"Genomic imbalances in 61 renal cancers from the proximal tubulus detected by comparative genomic hybridization","volume":"93","author":"Reutzel","year":"2001","journal-title":"Cytogenet. Cell Genet."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-4608(02)00544-7","article-title":"Analysis of kidney tumors by comparative genomic hybridization and conventional cytogenetics","volume":"137","author":"Rigola","year":"2002","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_73","first-page":"955","article-title":"Molecular cytogenetic characterization shows higher genetic homogeneity in conventional renal cell carcinoma compared to other kidney cancers","volume":"25","author":"Alimov","year":"2004","journal-title":"Int. J. Oncol."},{"key":"ref_74","first-page":"1183","article-title":"Comparative study of renal cell carcinoma by CGH, multicolor-FISH and conventional cytogenic banding analysis","volume":"14","author":"Sanjmyatav","year":"2005","journal-title":"Oncol. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/path.2239","article-title":"High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma","volume":"213","author":"Yoshimoto","year":"2007","journal-title":"J. Pathol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/ijc.24642","article-title":"Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays","volume":"125","author":"Chen","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.celrep.2016.02.024","article-title":"Multilevel genomics-based taxonomy of renal cell carcinoma","volume":"14","author":"Chen","year":"2016","journal-title":"Cell Rep."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/(SICI)1098-2264(199909)26:1<20::AID-GCC3>3.0.CO;2-6","article-title":"Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development","volume":"26","author":"Clifford","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"109524","DOI":"10.1016\/j.cellsig.2020.109524","article-title":"Role of oxygen and the HIF-pathway in polycystic kidney disease","volume":"69","author":"Buchholz","year":"2020","journal-title":"Cell. Signal."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/01.ASN.0000017223.49823.2A","article-title":"Expression of hypoxia-inducible factor-1 and -2 in hypoxic and ischemic rat kidneys","volume":"13","author":"Rosenberger","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"22642","DOI":"10.1074\/jbc.272.36.22642","article-title":"Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes","volume":"272","author":"Salceda","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/onc.2009.441","article-title":"Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics","volume":"29","author":"Semenza","year":"2010","journal-title":"Oncogene"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41581-019-0182-z","article-title":"Mechanisms of hypoxia signalling: New implications for nephrology","volume":"15","author":"Schodel","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMra043172","article-title":"Renal-cell carcinoma","volume":"353","author":"Cohen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jgg.2015.03.003","article-title":"The PI3K\/AKT pathway in renal cell carcinoma","volume":"42","author":"Guo","year":"2015","journal-title":"J. Genet. Genom."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":"Mutations of the VHL tumour suppressor gene in renal carcinoma","volume":"7","author":"Gnarra","year":"1994","journal-title":"Nat. Genet."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1200\/JCO.2012.45.2003","article-title":"Molecular genetics of clear-cell renal cell carcinoma","volume":"32","author":"Brugarolas","year":"2014","journal-title":"J. Am. Soc. Clin. Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cell.2018.03.043","article-title":"Deterministic evolutionary trajectories influence primary tumor growth: TRACERx renal","volume":"173","author":"Turajlic","year":"2018","journal-title":"Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.eururo.2012.09.005","article-title":"Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma","volume":"63","author":"Hakimi","year":"2013","journal-title":"Eur. Urol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ng.2699","article-title":"Integrated molecular analysis of clear-cell renal cell carcinoma","volume":"45","author":"Sato","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cancergen.2015.02.008","article-title":"The roles of chromatin-remodelers and epigenetic modifiers in kidney cancer","volume":"208","author":"Liao","year":"2015","journal-title":"Cancer Genet."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fped.2018.00016","article-title":"Renal cell carcinoma in von Hippel-Lindau disease-From tumor genetics to novel therapeutic strategies","volume":"6","author":"Kim","year":"2018","journal-title":"Front. Pediatr."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"658","DOI":"10.4161\/cbt.10.7.13247","article-title":"Signaling pathways in renal cell carcinoma","volume":"10","author":"Banumathy","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrurol.2010.47","article-title":"The genetic basis of kidney cancer: A metabolic disease","volume":"7","author":"Linehan","year":"2010","journal-title":"Nat. Rev. Urol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/sj.ki.5000221","article-title":"The VHL\/HIF oxygen-sensing pathway and its relevance to kidney disease","volume":"69","author":"Haase","year":"2006","journal-title":"Kidney Int."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"12864","DOI":"10.1074\/jbc.M001492200","article-title":"Cyclic AMP inhibits Akt activity by blocking the membrane localization of PDK1","volume":"276","author":"Kim","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1128\/MCB.24.1.200-216.2004","article-title":"mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1\/eukaryotic translation initiation factor 4E","volume":"24","author":"Fingar","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13059-020-02115-y","article-title":"The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation","volume":"21","author":"Kosti","year":"2020","journal-title":"Genome Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI72272","article-title":"Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease","volume":"124","author":"Harris","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP cells to a cAMP-dependent growth-stimulated phenotype","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease","volume":"16","author":"Tao","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/MCB.01259-08","article-title":"Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1","volume":"29","author":"Distefano","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2009040421","article-title":"Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1","volume":"21","author":"Shillingford","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1128\/MCB.22.20.7004-7014.2002","article-title":"Regulation of hypoxia-inducible factor 1a expression and function by the mammalian target or rapamycin","volume":"22","author":"Hudson","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"F1235","DOI":"10.1152\/ajprenal.00348.2010","article-title":"Hypoxia-inducible factor-1a (HIF-1a) and autophagy in polycystic kidney disease (PKD)","volume":"300","author":"Belibi","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1084\/jem.186.11.1873","article-title":"C-MYC-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent","volume":"186","author":"Trudel","year":"1997","journal-title":"J. Exp. Med."},{"key":"ref_108","first-page":"2210","article-title":"c-myc-induced apoptosis in polycystic kidney disease is independent of FasL\/Fas interaction","volume":"62","author":"Couillard","year":"2002","journal-title":"Cancer Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bbadis.2010.11.005","article-title":"Cyclic AMP-mediated cyst expansion","volume":"1812","author":"Wallace","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.juro.2012.08.030","article-title":"Succinate dehydrogenase kidney cancer: An aggressive example of the Warburg effect in cancer","volume":"188","author":"Ricketts","year":"2012","journal-title":"J. Urol."},{"key":"ref_111","first-page":"309","article-title":"Metabolism of the carcinoma cell","volume":"152","author":"Warburg","year":"1924","journal-title":"Biochem. Z."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1615\/CritRevEukarGeneExpr.v22.i1.20","article-title":"Carbon source metabolism and its regulation in cancer cells","volume":"22","author":"Yin","year":"2012","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"ref_113","first-page":"141","article-title":"Metabolic genes in cancer: Their roles in tumor progression and clinical implications","volume":"1805","author":"Furuta","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The role of carbonic anhydrase IX in cancer development: Links to hypoxia, acidosis, and beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1038\/sj.onc.1207764","article-title":"Strict regulation of CAIXG250\/MN by HIF-1\u03b1 in clear cell renal cell carcinoma","volume":"23","author":"Grabmaier","year":"2004","journal-title":"Oncogene"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.celrep.2018.06.106","article-title":"MTORC1 upregulation leads to accumulation of the oncometabolite fumarate in a mouse model of renal cell carcinoma","volume":"24","author":"Drusian","year":"2018","journal-title":"Cell Rep."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e15249","DOI":"10.1097\/MD.0000000000015249","article-title":"Renal cell carcinoma originating in the free wall of simple renal cyst: Two unusual case reports with literature review","volume":"98","author":"Lai","year":"2019","journal-title":"Medicine"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: The metabolic requirements of cell proliferation","volume":"324","author":"Cantley","year":"2009","journal-title":"Science"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"F726","DOI":"10.1152\/ajprenal.00551.2015","article-title":"A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease","volume":"310","author":"Kipp","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.cmet.2019.09.012","article-title":"Ketosis ameliorates renal cyst growth in polycystic kidney disease","volume":"30","author":"Torres","year":"2019","journal-title":"Cell Metab."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"29083","DOI":"10.1074\/jbc.270.49.29083","article-title":"Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-acting sequences","volume":"270","author":"Ebert","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.kint.2018.06.008","article-title":"HIF-1\u03b1 promotes cyst progression in a mouse model of autosomal dominant polycystic kidney disease","volume":"94","author":"Kraus","year":"2018","journal-title":"Kidney Int."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2353\/ajpath.2007.060455","article-title":"Involvement of hypoxia-inducible transcription factors in polycystic kidney disease","volume":"170","author":"Bernhardt","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1681\/ASN.2013030209","article-title":"Hypoxia-inducible factor-1alpha causes renal cyst expansion through calcium-activated chloride secretion","volume":"25","author":"Buchholz","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000500478","article-title":"Systemic succinate, hypoxia-inducible Factor-1 alpha, and IL-1\u03b2 gene expression in autosomal dominant polycystic kidney disease with and without hypertension","volume":"9","author":"Kocyigit","year":"2019","journal-title":"Cardiorenal Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1681\/ASN.2018010039","article-title":"Lipid peroxidation drives renal cyst growth in vitro through activation of TMEM16A","volume":"30","author":"Schreiber","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fncel.2015.00086","article-title":"Cancer as a channelopathy: Ion channels and pumps in tumor development and progression","volume":"9","author":"Litan","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"ref_129","first-page":"1140","article-title":"NCC27, a homolog of intracellular CI-channel p64, is expressed in brush border of renal proximal tubule","volume":"274","author":"Tulk","year":"1998","journal-title":"Am. J. Physiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.21873\/cgp.20135","article-title":"Intracellular chloride ion channel protein-1 expression in clear cell renal cell carcinoma","volume":"16","author":"Nesiu","year":"2019","journal-title":"Cancer Genom. Proteom."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3389\/fphar.2018.00899","article-title":"Inhibition of chloride intracellular channel I (CLIC1) as biguanide class-effect to impair human glioblastoma stem cell viability","volume":"9","author":"Barbieri","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"9298","DOI":"10.1074\/jbc.M308444200","article-title":"The intracellular chloride ion channel protein CLIC1 undergoes a redox-controlled structural transition","volume":"279","author":"Littler","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00249-009-0450-0","article-title":"Oxidation promotes insertion of the CLIC1 chloride intracellular channel into the membrane","volume":"39","author":"Goodchild","year":"2009","journal-title":"Eur. Biophys. J."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/jnci\/djt278","article-title":"Functional role of CLIC1 ion channel in glioblastoma-derived stem\/progenitor cells","volume":"105","author":"Setti","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s13277-011-0223-0","article-title":"The expression and clinical significance of CLIC1 and HSP27 in lung adenocarcinoma","volume":"32","author":"Wang","year":"2011","journal-title":"Tumour Biol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1158\/1541-7786.MCR-14-0249","article-title":"Relocation of CLIC1 promotes tumor cell invasion and colonization of fibrin","volume":"13","author":"Gurski","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"C386","DOI":"10.1152\/ajpcell.1996.270.1.C389","article-title":"A role for CFTR in human autosomal dominant polycystic kidney disease","volume":"270","author":"Hanaoka","year":"1996","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"966","DOI":"10.12659\/MSM.899341","article-title":"Lower cystic fibrosis transmembrane conductance regulator (CFTR) promotes the proliferation and migration of endometrial carcinoma","volume":"23","author":"Xia","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"F1412","DOI":"10.1152\/ajprenal.00692.2011","article-title":"Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl- secretion by human autosomal dominant polycystic kidney cells","volume":"303","author":"Pinto","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0022-5347(01)64303-9","article-title":"Hypercalcemia in patients with metastatic renal cell carcinoma: Effect of nephrectomy and metabolic evaluation","volume":"158","author":"Walther","year":"1997","journal-title":"J. Urol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5527\/wjn.v5.i1.76","article-title":"Role of calcium in polycystic kidney disease: From signaling to pathology","volume":"5","author":"Mangolini","year":"2016","journal-title":"World J. Nephrol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrneph.2015.39","article-title":"Vasopressin and disruption of calcium signaling in polycystic kidney disease","volume":"11","author":"Chebib","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1681\/ASN.2005060645","article-title":"Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells","volume":"17","author":"Yamaguchi","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMra1010172","article-title":"Ciliopathies","volume":"364","author":"Hildebrandt","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2046-2530-2-2","article-title":"Reduced cilia frequencies in human renal cell carcinomas versus neighboring parenchymal tissue","volume":"2","author":"Basten","year":"2013","journal-title":"Cilia"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3934\/molsci.2013.1.27","article-title":"The roles of primary cilia in polycystic kidney disease","volume":"1","author":"Kathem","year":"2014","journal-title":"AIMS Mol. Sci."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1681\/ASN.2006111215","article-title":"Role of primary cilia in the pathogenesis of polycystic kidney disease","volume":"18","author":"Yoder","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/emboj.2008.96","article-title":"pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation","volume":"27","author":"Frew","year":"2008","journal-title":"EMBO J."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1681\/ASN.2013090984","article-title":"Beta-catenin links von hippel-lindau to aurora kinase A and loss of primary cilia in renal cell carcinoma","volume":"26","author":"Dere","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1158\/0008-5472.CAN-07-0391","article-title":"Von hippel-lindau: A tumor suppressor links microtubules to ciliogenesis and cancer development","volume":"67","author":"Kuehn","year":"2007","journal-title":"Cancer Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00018-012-1052-z","article-title":"The role of the cilium in normal and abnormal cell cycles: Emphasis on renal cystic pathologies","volume":"70","author":"Pan","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.cell.2007.04.035","article-title":"HEF1-dependent aurora A activation induces disassembly of the primary cilium","volume":"129","author":"Pugacheva","year":"2007","journal-title":"Cell"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1681\/ASN.2006020181","article-title":"Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein","volume":"17","author":"Esteban","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_154","first-page":"814","article-title":"Aurora A kinase activity influences calcium signaling in kidney cells","volume":"11","author":"Plotnikova","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"12859","DOI":"10.1073\/pnas.1405362111","article-title":"Nedd9 restrains renal cystogenesis in Pkd1\u2212\/\u2212 mice","volume":"111","author":"Nikonova","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ng.2715","article-title":"Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease","volume":"45","author":"Ma","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fonc.2015.00228","article-title":"Opposing effects of inhibitors of Aurora-A and EGFR in autosomal-dominant polycystic kidney disease","volume":"5","author":"Nikonova","year":"2015","journal-title":"Front. Oncol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/gm275","article-title":"A systems-biology approach to understanding the ciliopathy disorders","volume":"3","author":"Lee","year":"2011","journal-title":"Genome Med."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"R378","DOI":"10.1016\/S0960-9822(02)00877-1","article-title":"Polycystin-2 localizes to kidney cilia and the ciliary level is elevated in orpk mice with polycystic kidney disease","volume":"12","author":"Pazour","year":"2002","journal-title":"Curr. Biol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1097\/01.ASN.0000029587.47950.25","article-title":"The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia","volume":"13","author":"Yoder","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1126\/science.8191288","article-title":"Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice","volume":"264","author":"Moyer","year":"1994","journal-title":"Science"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1083\/jcb.200107108","article-title":"The intraflagellar transport protein, IFT88, is essential for vertebrate photoreceptor assembly and maintenance","volume":"157","author":"Pazour","year":"2002","journal-title":"J. Cell Biol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1242\/dev.01772","article-title":"Cilia-driven fluid flow in the zebrafish pronephros, brain and Kupffer\u2019s vesicle is required for normal organogenesis","volume":"132","author":"Olale","year":"2005","journal-title":"Development"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1681\/ASN.2006040412","article-title":"Polycystin-2 immunolocalization and function in zebrafish","volume":"17","author":"Obara","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1242\/dmm.003194","article-title":"The ADPKD genes pkd1a\/b and pkd2 regulate extracellular matrix formation","volume":"3","author":"Mangos","year":"2010","journal-title":"Dis. Model Mech."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Gamberi, C., Hipfner, D.R., Trudel, M., and Lubell, W.D. (2017). Bicaudal C mutation causes myc and TOR pathway up-regulation and polycystic kidney disease-like phenotypes in drosophila. PLoS Genet., 13.","DOI":"10.1371\/journal.pgen.1006694"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41388-019-1059-0","article-title":"Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy","volume":"39","author":"Sinha","year":"2020","journal-title":"Oncogene"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1038\/s41598-019-43002-2","article-title":"Sensory primary cilium is a responsive cAMP microdomain in renal epithelia","volume":"9","author":"Sherpa","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1158\/1535-7163.MCT-17-0925","article-title":"MicroRNA-203 inhibits long noncoding RNA hotair and regulates tumorigenesis through epithelial-to-mesenchymal transition pathway in renal cell carcinoma","volume":"17","author":"Dasgupta","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.2147\/OTT.S190239","article-title":"LncRNA PVT1 promotes proliferation, invasion and epithelial\u2013mesenchymal transition of renal cell carcinoma cells through downregulation of miR-16-5p","volume":"12","author":"Ren","year":"2019","journal-title":"OncoTargets Ther."},{"key":"ref_172","first-page":"3173","article-title":"Silencing of the long non-coding RNA GHET1 inhibits cell proliferation and migration of renal cell carcinoma through epithelial-mesenchymal transition","volume":"17","author":"Xie","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41585-018-0023-z","article-title":"Epigenetics in renal cell cancer: Mechanisms and clinical applications","volume":"15","author":"Joosten","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1681\/ASN.2012030321","article-title":"MicroRNAs regulate renal tubule maturation through modulation of Pkd1","volume":"23","author":"Patel","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s41417-019-0149-z","article-title":"MicroRNA-200 family expression analysis in metastatic clear cell renal cell carcinoma patients","volume":"27","author":"Gilyazova","year":"2020","journal-title":"Cancer Gene Ther."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.3892\/ol.2016.4364","article-title":"Demethylation drug 5-AZA-2\u2032-deoxycytidine-induced upregulation of miR-200c inhibits the migration, invasion and epithelial-mesenchymal transition of clear cell renal cell carcinoma in vitro","volume":"11","author":"Jiang","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms14395","article-title":"MicroRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism","volume":"8","author":"Hajarnis","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.juro.2009.09.086","article-title":"The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma","volume":"183","author":"Chow","year":"2010","journal-title":"J. Urol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jmoldx.2012.02.003","article-title":"The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma","volume":"14","author":"Faragalla","year":"2012","journal-title":"J. Mol. Diagn."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1681\/ASN.2015060634","article-title":"MicroRNA-21 aggravates cyst growth in a model of polycystic kidney disease","volume":"27","author":"Lakhia","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.12659\/MSM.910054","article-title":"Long non-coding RNA DUXAP8 enhances renal cell carcinoma progression via downregulating miR-126","volume":"24","author":"Huang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3892\/mmr.2016.5337","article-title":"Downregulation of lncRNA CASC2 by microRNA-21 increases the proliferation and migration of renal cell carcinoma cells","volume":"14","author":"Cao","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"9388","DOI":"10.1074\/jbc.RA118.001723","article-title":"Long noncoding RNA Hoxb3os is dysregulated in autosomal dominant polycystic kidney disease and regulates mTOR signaling","volume":"293","author":"Aboudehen","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1038\/mtna.2015.23","article-title":"siRNA versus miRNA as therapeutics for gene silencing","volume":"4","author":"Lam","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_185","first-page":"295","article-title":"Potential clinical applications of microRNAs as biomarkers for renal cell Carcinoma","volume":"71","author":"Mytsyk","year":"2018","journal-title":"Cent. Eur. J. Urol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.canlet.2016.04.011","article-title":"MicroRNA-17~92 inhibits colorectal cancer progression by targeting angiogenesis","volume":"376","author":"Ma","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat. Med."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"F122","DOI":"10.1152\/ajprenal.00352.2017","article-title":"PPAR\u03b1 agonist fenofibrate enhances fatty acid \u03b2-oxidation and attenuates polycystic kidney and liver disease in mice","volume":"314","author":"Lakhia","year":"2018","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/j.ddmod.2013.10.001","article-title":"MicroRNAs and polycystic kidney disease","volume":"10","author":"Noureddine","year":"2013","journal-title":"Drug Discov. Today Dis. Models"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.3892\/mmr.2016.5160","article-title":"MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/cdd.2011.104","article-title":"Evidence that CED-9\/Bcl2 and CED-4\/Apaf-1 localization is not consistent with the current model for C. elegans apoptosis induction","volume":"19","author":"Pourkarimi","year":"2012","journal-title":"Cell Death Differ."},{"key":"ref_192","unstructured":"(2021, February 27). Flybase. Available online: flybase.org."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1016\/j.cub.2018.09.026","article-title":"Non-coding RNA expression, function, and variation during Drosophila embryogenesis","volume":"28","author":"Schor","year":"2018","journal-title":"Curr. Biol."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Li, K., Tian, Y., Yuan, Y., Fan, X., Yang, M., He, Z., and Yang, D. (2019). Insights into the functions of LncRNAs in Drosophila. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184646"},{"key":"ref_195","first-page":"5697436","article-title":"Modeling renal disease \u201cOn the fly\u201d","volume":"2018","author":"Gamberi","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1186\/gb-2004-5-9-r69","article-title":"Function-informed transcriptome analysis of Drosophila renal tubule","volume":"5","author":"Wang","year":"2004","journal-title":"Genome Biol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/nar\/30.1.149","article-title":"Homophila: Human disease gene cognates in Drosophila","volume":"30","author":"Chien","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.devcel.2007.10.002","article-title":"Bicaudal-C recruits CCR4-NOT deadenylase to target mRNAs and regulates oogenesis, cytoskeletal organization, and its own expression","volume":"13","author":"Chicoine","year":"2007","journal-title":"Dev. Cell"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"141386","DOI":"10.1155\/2012\/141386","article-title":"The Bic-C family of developmental translational regulators","volume":"2012","author":"Gamberi","year":"2012","journal-title":"Comp. Funct. Genom."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Millet-Boureima, C., Chingle, R., Lubell, W.D., and Gamberi, C. (2019). Cyst reduction in a polycystic kidney disease Drosophila model using Smac mimics. Biomedicines, 7.","DOI":"10.3390\/biomedicines7040082"},{"key":"ref_201","first-page":"147","article-title":"Drug discovery and chemical probing in Drosophila","volume":"64","author":"Gamberi","year":"2020","journal-title":"Genome"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3724\/SP.J.1005.2010.00115","article-title":"Regulatory functions of Pax gene family in Drosophila development","volume":"32","author":"Li","year":"2010","journal-title":"Yi Chuan"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"26852","DOI":"10.18632\/oncotarget.25516","article-title":"SMAD proteins directly suppress PAX2 transcription downstream of transforming growth factor-beta 1 (TGF-\u03b21) signalling in renal cell carcinoma","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1101\/gad.835000","article-title":"Regulation of cellular growth by the Drosophila target of rapamycin dTOR","volume":"14","author":"Zhang","year":"2000","journal-title":"Genes Dev."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"a014324","DOI":"10.1101\/cshperspect.a014324","article-title":"Myc function in Drosophila","volume":"3","author":"Gallant","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/414768a","article-title":"c-Myc regulates mammalian body size by controlling cell number but not cell size","volume":"414","author":"Trumpp","year":"2001","journal-title":"Nature"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1006\/dbio.2000.9680","article-title":"Drosophila PTEN regulates cell growth and proliferation through PI3K-dependent and -independent pathways","volume":"221","author":"Gao","year":"2000","journal-title":"Dev. Biol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.febslet.2012.04.032","article-title":"Systemic VHL gene functions and the VHL disease","volume":"586","author":"Bader","year":"2012","journal-title":"FEBS Lett."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1038\/sj.onc.1203611","article-title":"Tracheal development and the von Hippel-Lindau tumor suppressor homolog in Drosophila","volume":"19","author":"Adryan","year":"2000","journal-title":"Oncogene"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1128\/MCB.01578-09","article-title":"Drosophila von Hippel-Lindau tumor suppressor gene function in epithelial tubule morphogenesis","volume":"30","author":"Hsouna","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/onc.2011.442","article-title":"Complex cellular functions of the von Hippel-Lindau tumor suppressor gene: Insights from model organisms","volume":"31","author":"Hsu","year":"2012","journal-title":"Oncogene"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1146\/annurev.cellbio.19.031403.160043","article-title":"Branching morphogenesis of the Drosophila tracheal system","volume":"19","author":"Ghabrial","year":"2003","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1101\/gad.1096903","article-title":"Drosophila awd, the homolog of human nm23, regulates FGF receptor levels and functions synergistically with shi\/dynamin during tracheal development","volume":"17","author":"Dammai","year":"2003","journal-title":"Genes Dev."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1242\/dev.042804","article-title":"Drosophila VHL tumor-suppressor gene regulates epithelial morphogenesis by promoting microtubule and aPKC stability","volume":"137","author":"Duchi","year":"2010","journal-title":"Development"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3389\/fphys.2019.00619","article-title":"Comparative expression profiling of wild type Drosophila Malpighian tubules and von Hippel-Lindau haploinsufficient mutant","volume":"10","author":"Ignesti","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"17628","DOI":"10.18632\/oncotarget.12192","article-title":"Haploinsufficiency in tumor predisposition syndromes: Altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation","volume":"8","author":"Peri","year":"2017","journal-title":"Oncotarget"},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Peri, S., Devarajan, K., Yang, D.H., Knudson, A.G., and Balachandran, S. (2013). Meta-analysis identifies NF-B as a therapeutic target in renal cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076746"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"eaav6528","DOI":"10.1126\/sciadv.aav6528","article-title":"A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer","volume":"5","author":"Bangi","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ydbio.2009.03.001","article-title":"Regulation of Drosophila embryonic tracheogenesis by dVHL and hypoxia","volume":"329","author":"Mortimer","year":"2009","journal-title":"Dev. Biol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.devcel.2008.01.020","article-title":"Cell autonomy of HIF effects in Drosophila: Tracheal cells sense hypoxia and induce terminal branch sprouting","volume":"14","author":"Centanin","year":"2008","journal-title":"Dev. Cell"},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Li, Y., Padmanabha, D., Gentile, L.B., Dumur, C., Beckstead, R.B., and Baker, K.D. (2013). HIF- and non-HIF-regulated hypoxic responses require the estrogen-related in Drosophila melanogaster. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003230"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1242\/dev.124.22.4571","article-title":"The Drosophila tango gene encodes a bHLH-PAS protein that is orthologous to mammalian Arnt and controls CNS midline and tracheal development","volume":"124","author":"Sonnenfeld","year":"1997","journal-title":"Development"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.1199643","article-title":"Interaction between Notch and Hif-in development and survival of Drosophila blood cells","volume":"332","author":"Mukherjee","year":"2011","journal-title":"Science"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0092-8674(02)00676-1","article-title":"Developmental control of blood cell migration by the Drosophila VEGF pathway","volume":"108","author":"Cho","year":"2002","journal-title":"Cell"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s10495-009-0361-7","article-title":"Correcting developmental errors by apoptosis: Lessons from Drosophila JNK signaling","volume":"14","author":"Igaki","year":"2009","journal-title":"Apoptosis"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ceb.2015.07.003","article-title":"Drosophila immune cell migration and adhesion during embryonic development and larval immune responses","volume":"36","author":"Ratheesh","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Read, R.D., Cavenee, W.K., Furnari, F.B., and Thomas, J.B. (2009). A Drosophila model for EGFR-Ras and PI3K-dependent human glioma. PLoS Genet., 5.","DOI":"10.1371\/journal.pgen.1000374"},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Buchon, N., Broderick, N.A., Kuraishi, T., and Lemaitre, B. (2010). Drosophila EGFR pathway coordinates stem cell proliferation and gut remodeling following infection. BMC Biol., 8.","DOI":"10.1186\/1741-7007-8-152"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jinsphys.2017.07.010","article-title":"Live imaging using a FRET glucose sensor reveals glucose delivery to all cell types in the Drosophila brain","volume":"106","author":"Volkenhoff","year":"2018","journal-title":"J. Insect Physiol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1128\/MCB.24.8.3077-3088.2004","article-title":"Differential targeting of two distinct SWI\/SNF-related Drosophila chromatin-remodeling complexes","volume":"24","author":"Mohrmann","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature08966","article-title":"Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB","volume":"465","author":"Scheuermann","year":"2010","journal-title":"Nature"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1038\/s41467-018-06186-1","article-title":"A bidentate Polycomb Repressive-Deubiquitinase complex is required for efficient activity on nucleosomes","volume":"9","author":"Foglizzo","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nsmb.2477","article-title":"Chromatin proteins captured by ChIP-mass spectrometry are linked to dosage compensation in Drosophila","volume":"20","author":"Wang","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1101\/gad.845700","article-title":"Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin","volume":"14","author":"Oldham","year":"2000","journal-title":"Genes Dev."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0092-8674(00)81512-3","article-title":"Drosophila myc regulates cellular growth during development","volume":"98","author":"Johnston","year":"1999","journal-title":"Cell"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1101\/gad.13.24.3244","article-title":"Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico\/PI3-kinase signaling pathway","volume":"13","author":"Goberdhan","year":"1999","journal-title":"Genes Dev."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1242\/dev.126.23.5365","article-title":"PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development","volume":"126","author":"Huang","year":"1999","journal-title":"Development"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1242\/dev.010389","article-title":"Programmed cell death of primordial germ cells in Drosophila is regulated by p53 and the Outsiders monocarboxylate transporter","volume":"135","author":"Yamada","year":"2008","journal-title":"Development"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/cdd.2009.182","article-title":"Dual roles of Drosophila p53 in cell death and cell differentiation","volume":"17","author":"Fan","year":"2010","journal-title":"Cell Death Differ."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/cdd.2011.113","article-title":"A dp53\/JNK-dependent feedback amplification loop is essential for the apoptotic response to stress in Drosophila","volume":"19","author":"Shlevkov","year":"2012","journal-title":"Cell Death Differ."},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"Rougeot, J., Renard, M., Randsholt, N.B., Peronnet, F., and Mouchel-Vielh, E. (2013). The Elongin complex antagonizes the chromatin factor corto for vein versus intervein cell identity in Drosophila wings. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0077592"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00280-015-2770-3","article-title":"Targeted therapies for treatment of renal cell carcinoma: Recent advances and future perspectives","volume":"76","author":"Minguet","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1158\/1078-0432.CCR-07-4719","article-title":"Temsirolimus, an inhibitor of mammalian target of rapamycin","volume":"14","author":"Rini","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1158\/1078-0432.CCR-13-2345","article-title":"Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy","volume":"20","author":"Voss","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1158\/1078-0432.CCR-15-2631","article-title":"Mutations in TSC1, TSC2, and MTOR are associated with response to rapalogs in patients with metastatic renal cell carcinoma","volume":"22","author":"Kwiatkowski","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"10547","DOI":"10.18632\/oncotarget.7234","article-title":"Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus","volume":"7","author":"Lim","year":"2016","journal-title":"Oncotarget"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)","volume":"21","author":"Wahl","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000104818","article-title":"Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease","volume":"30","author":"Wu","year":"2007","journal-title":"Kidney Blood Press. Res."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2215\/CJN.01360210","article-title":"Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases","volume":"5","author":"Torres","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"403280","DOI":"10.1155\/2013\/403280","article-title":"Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitors","volume":"2013","author":"Zaza","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40620-014-0103-y","article-title":"mTOR inhibitors and renal allograft: Yin and Yang","volume":"27","author":"Zaza","year":"2014","journal-title":"J. Nephrol."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1756287217713902","article-title":"Sunitinib in the treatment of renal cell carcinoma: An update on recent evidence","volume":"9","author":"Rizzo","year":"2017","journal-title":"Ther. Adv. Urol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12967-019-2047-4","article-title":"Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results","volume":"17","author":"Facchini","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1517\/14656566.7.4.453","article-title":"Sorafenib","volume":"7","author":"Rini","year":"2006","journal-title":"Exp. Opin. Pharmacother."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.clgc.2014.07.007","article-title":"Sorafenib treatment of advanced renal cell carcinoma patients in daily practice: The large international PREDICT study","volume":"13","author":"Ma","year":"2015","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/13543784.2018.1472235","article-title":"Lenvatinib for the treatment of renal cell carcinoma","volume":"27","author":"Roviello","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S1470-2045(15)00290-9","article-title":"Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: A randomised, phase 2, open-label, multicentre trial","volume":"16","author":"Motzer","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/17425255.2018.1455826","article-title":"Lenvatinib in the management of metastatic renal cell carcinoma: A promising combination therapy?","volume":"14","author":"Lolli","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3233\/KCA-180041","article-title":"Randomized phase 2 study of Trebananib (AMG 386) with or without continued anti-vascular endothelial growth factor therapy in patients with renal cell carcinoma who have progressed on Bevacizumab, Pazopanib, Sorafenib, or Sunitinib\u2014Results of NCI\/CTEP protocol 9048","volume":"3","author":"Semrad","year":"2019","journal-title":"Kidney Cancer"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"41857","DOI":"10.18632\/oncotarget.9621","article-title":"Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/cncr.32061","article-title":"A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma","volume":"125","author":"Voss","year":"2019","journal-title":"Cancer"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ctrv.2014.12.013","article-title":"PD-1 blockade therapy in renal cell carcinoma: Current studies and future promises","volume":"41","author":"Massari","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"Blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"709s","DOI":"10.1158\/1078-0432.CCR-06-1868","article-title":"Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy","volume":"13","author":"Thompson","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1200\/jco.2014.32.15_suppl.4585","article-title":"PD-L1 expression in primary clear cell renal cell carcinomas (ccRCCs) and their metastases","volume":"32","author":"Callea","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"166","DOI":"10.7150\/jca.8167","article-title":"PD-L1 expression in clear cell renal cell carcinoma: An analysis of nephrectomy and sites of metastases","volume":"5","author":"Jilaveanu","year":"2014","journal-title":"J. Cancer"},{"key":"ref_268","doi-asserted-by":"crossref","unstructured":"Kammerer-Jacquet, S.F., Deleuze, A., Saout, J., Mathieu, R., Laguerre, B., Verhoest, G., Dugay, F., Belaud-Rotureau, M.A., Bensalah, K., and Rioux-Leclercq, N. (2019). Targeting the PD-1\/PD-L1 pathway in renal cell carcinoma. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20071692"},{"key":"ref_269","doi-asserted-by":"crossref","unstructured":"Deleuze, A., Saout, J., Dugay, F., Peyronnet, B., Mathieu, R., Verhoest, G., Bensalah, K., Crouzet, L., Laguerre, B., and Belaud-Rotureau, M.A. (2020). Immunotherapy in renal cell carcinoma: The future is now. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072532"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/CAD.0b013e32832ced78","article-title":"Smac mimetics as new cancer therapeutics","volume":"20","author":"Chen","year":"2009","journal-title":"Anticancer Drugs"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0006-291X(03)00621-1","article-title":"Mitochondrial intermembrane proteins in cell death","volume":"304","author":"Festjens","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"36152","DOI":"10.1074\/jbc.C000533200","article-title":"Molecular determinants of the caspase-promoting activity of Smac\/DIABLO and its role in the death receptor pathway","volume":"275","author":"Srinivasula","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/35065125","article-title":"A conserved XIAP-interaction motif in caspase-9 and Smac\/DIABLO regulates caspase activity and apoptosis","volume":"410","author":"Srinivasula","year":"2001","journal-title":"Nature"},{"key":"ref_274","doi-asserted-by":"crossref","unstructured":"Lalaoui, N., and Vaux, D.L. (2018). Recent advances in understanding inhibitor of apoptosis proteins. F1000Research, 7.","DOI":"10.12688\/f1000research.16439.1"},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1021\/acs.jmedchem.8b01668","article-title":"Inhibitor of apoptosis protein (IAP) antagonists in anticancer discovery: Current status and perspectives","volume":"62","author":"Cong","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1200\/JCO.2005.02.191","article-title":"Downregulation of Smac\/DIABLO expression in renal cell carcinoma and its prognostic significance","volume":"23","author":"Mizutani","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/sj.bjc.6602127","article-title":"Disturbed balance of expression between XIAP and Smac\/DIABLO during tumour progression in renal cell carcinomas","volume":"91","author":"Yan","year":"2004","journal-title":"Br. J. Cancer"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00432-007-0317-7","article-title":"Expression levels of the mitochondrial IAP antagonists Smac\/DIABLO and Omi\/HtrA2 in clear-cell renal cell carcinomas and their prognostic value","volume":"134","author":"Kempkensteffen","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_279","doi-asserted-by":"crossref","unstructured":"Millet-Boureima, C. (2019). Cyst Reduction in a First-in-Kind Drosophila Model of Polycystic Kidney Disease. [Master\u2019s Thesis, Concordia University].","DOI":"10.3390\/molecules25225477"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1681\/ASN.2013020176","article-title":"Smac-mimetic-induced epithelial cell death reduces the growth of renal cysts","volume":"24","author":"Fan","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nm1783","article-title":"A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1093\/emboj\/cdf306","article-title":"Eiger, a TNF superfamily ligand that triggers the Drosophila JNK pathway","volume":"21","author":"Igaki","year":"2002","journal-title":"EMBO J."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"28372","DOI":"10.1074\/jbc.C200324200","article-title":"Wengen, a member of the Drosophila tumor necrosis factor receptor superfamily, is required for Eiger signaling","volume":"277","author":"Kanda","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0960-9822(02)00954-5","article-title":"Evolution of TNF signaling mechanisms: JNK-dependent apoptosis triggered by Eiger, the Drosophila homolog of the TNF superfamily","volume":"12","author":"Moreno","year":"2002","journal-title":"Curr. Biol."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature14298","article-title":"The Drosophila TNF receptor Grindelwald couple loss of cell polarity and neoplastic growth","volume":"522","author":"Andersen","year":"2015","journal-title":"Nature"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0959-8049(94)90079-5","article-title":"Tumor necrosis factor-a, interleukin-1b and interleukin-6 in patients with renal cell carcinoma","volume":"30","author":"Dosquet","year":"1994","journal-title":"Eur. J. Cancer"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/sj.bjc.6600257","article-title":"Interleukin-6, tumor necrosis factor alpha and interleukin-1beta in patients with renal cell carcinoma","volume":"86","author":"Yoshida","year":"2002","journal-title":"Br. J. Cancer"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/ijc.29137","article-title":"Expression of TNF- and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas","volume":"136","author":"Mikami","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1349-7006.2008.00756.x","article-title":"Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells","volume":"99","author":"Chuang","year":"2008","journal-title":"Cancer Sci."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1210\/er.2018-00084","article-title":"Melatonin as a hormone: New physiological and clinical insights","volume":"39","year":"2018","journal-title":"Endocr. Rev."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/jcmm.14769","article-title":"Melatonin preconditioning is an effective strategy for mesenchymal stem cell-based therapy for kidney disease","volume":"24","author":"Zhao","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"ref_292","first-page":"539","article-title":"Increase in lifespan of rats following polypeptide pineal extract treatment","volume":"17","author":"Dilman","year":"1979","journal-title":"Exp. Pathol."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0047-6374(97)01897-6","article-title":"Effect of melatonin and pineal peptide preparation epithalamin on life span and free radical oxidation in Drosophila melanogaster","volume":"97","author":"Anisimov","year":"1997","journal-title":"Mech. Ageing Dev."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"B311","DOI":"10.1093\/gerona\/56.7.B311","article-title":"Melatonin increases both life span and tumor incidence in female CBA mice","volume":"56","author":"Anisimov","year":"2001","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bbabio.2006.03.012","article-title":"Melatonin as antioxidant, geroprotector and anticarcinogen","volume":"1757","author":"Anisimov","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"e12370","DOI":"10.1111\/jpi.12370","article-title":"Cancer metastasis: Mechanisms of inhibition by melatonin","volume":"62","author":"Su","year":"2017","journal-title":"J. Pineal Res."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12935-019-0853-7","article-title":"Melatonin and non-small cell lung cancer: New insights into signaling pathways","volume":"19","author":"Pourhanifeh","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-079X.2004.00165.x","article-title":"Mechanisms of cancer inhibition by melatonin","volume":"37","author":"Reiter","year":"2004","journal-title":"J. Pineal Res."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"39896","DOI":"10.18632\/oncotarget.16379","article-title":"Melatonin for the prevention and treatment of cancer","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"ref_300","doi-asserted-by":"crossref","unstructured":"Reiter, R.J., Rosales-Corral, S.A., Tan, D.X., Acuna-Castroviejo, D., Qin, L., Yang, S.F., and Xu, K. (2017). Melatonin, a full service and anti-cancer agent: Inhibition of initiation, progression and metastasis. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18040843"},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jpi.12140","article-title":"Additional benefit of combined therapy with melatonin and apoptotic adipose-derived mesenchymal stem cell against sepsis-induced kidney injury","volume":"57","author":"Chen","year":"2014","journal-title":"J. Pineal Res."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10735-019-09812-4","article-title":"Melatonin preconditioning of bone-marrow derived mesenchymal stem cells promotes their engraftment and improves renal regeneration in a rat model of chronic kidney disease","volume":"50","author":"Saberi","year":"2019","journal-title":"J. Mol. Hist."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fendo.2019.00249","article-title":"Melatonin synthesis and function: Evolutionary history in animals and plants","volume":"10","author":"Zhao","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/jpi.12308","article-title":"Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-DNA-binding activity","volume":"60","author":"Lin","year":"2016","journal-title":"J. Pineal Res."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/jpi.12102","article-title":"Transcriptional and post-transcriptional regulation of Bim controls apoptosis in melatonin-treated human renal cancer Caki cells","volume":"56","author":"Park","year":"2014","journal-title":"J. Pineal Res."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s12935-020-01531-1","article-title":"Melatonin and urological cancers: A new therapeutic approach","volume":"20","author":"Pourhanifeh","year":"2020","journal-title":"Cancer Cell Int."},{"key":"ref_307","doi-asserted-by":"crossref","unstructured":"Millet-Boureima, C., Rozencwaig, R., Polyak, F., and Gamberi, C. (2020). Cyst reduction by melatonin in a novel Drosophila model of polycystic kidney disease. Molecules, 25.","DOI":"10.3390\/molecules25225477"},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1471-4914(01)01953-0","article-title":"A \u201ctwo-hit\u201d model of cystogenesis in autosomal dominant polycystic kidney disease?","volume":"7","author":"Pei","year":"2001","journal-title":"Trends Mol. Med."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1681\/ASN.2010030328","article-title":"What is the role of somatic mutation in autosomal dominant polycystic kidney disease","volume":"21","author":"Harris","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"24","DOI":"10.12703\/P6-24","article-title":"Polycystic kidney disease\u2014Where gene dosage counts","volume":"6","author":"Eccles","year":"2014","journal-title":"F1000Prime Rep."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrneph.2015.46","article-title":"The hallmarks of cancer: Relevance to the pathogenesis of polycystic kidney disease","volume":"11","author":"Geynisman","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11255-018-1951-5","article-title":"The association between autosomal dominant polycystic kidney disease and cancer","volume":"51","author":"Sun","year":"2019","journal-title":"Int. Urol. Nephrol."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"e20071","DOI":"10.1097\/MD.0000000000020071","article-title":"Comprehensive analysis of mutations of renal cell carcinoma in an autosomal dominant polycystic kidney disease patient","volume":"99","author":"Shim","year":"2020","journal-title":"Medicine"},{"key":"ref_314","first-page":"279","article-title":"An hereditary tumor in the fruit fly, Drosophila","volume":"3","author":"Stark","year":"1918","journal-title":"Cancer Res."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1073\/pnas.5.12.573","article-title":"A benign tumor that is hereditary in Drosophila","volume":"5","author":"Stark","year":"1919","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jez.1400270404","article-title":"An hereditary tumor","volume":"27","author":"Stark","year":"1919","journal-title":"J. Exp. Zool."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/genetics\/9.4.343","article-title":"Two new hereditary tumors in Drosophila","volume":"9","author":"Wilson","year":"1924","journal-title":"Genetics"},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/bs.ctdb.2015.11.037","article-title":"Cancer in Drosophila: Imaginal discs as a model for epithelial tumor formation","volume":"116","author":"Herranz","year":"2016","journal-title":"Curr. Top. Dev. Biol."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1126\/science.1088474","article-title":"A genetic screen in Drosophila for metastatic behavior","volume":"302","author":"Pagliarini","year":"2003","journal-title":"Science"},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrc.2018.15","article-title":"Cell motility in cancer invasion and metastasis: Insights from simple model organisms","volume":"18","author":"Stuelten","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_321","first-page":"27","article-title":"Drosophila as a model for context-dependent tumorigenesis","volume":"229","author":"Tipping","year":"2014","journal-title":"J. Cell Physiol."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nature08702","article-title":"Interaction between Ras(V12) and scribbled clones induces tumour growth and invasion","volume":"463","author":"Wu","year":"2010","journal-title":"Nature"},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1093\/emboj\/cdg548","article-title":"scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila","volume":"22","author":"Brumby","year":"2003","journal-title":"EMBO J."},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"8688","DOI":"10.1038\/sj.onc.1208023","article-title":"The human protein Hugl-1 substitutes for Drosophila lethal giant larvae tumour suppressor function in vivo","volume":"23","author":"Grifoni","year":"2004","journal-title":"Oncogene"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.cub.2006.04.042","article-title":"Loss of cell polarity drives tumor growth and invasion through JNK activation in Drosophila","volume":"16","author":"Igaki","year":"2006","journal-title":"Curr. Biol."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-3-030-23629-8_3","article-title":"Drosophila models of cell polarity and cell competition in tumourigenesis","volume":"1167","author":"Portela","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1016\/j.cub.2018.08.035","article-title":"Warburg effect metabolism drives neoplasia in a Drosophila genetic model of epithelial cancer","volume":"28","author":"Eichenlaub","year":"2018","journal-title":"Curr. Biol."},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2217\/pme.10.65","article-title":"Drosophila as a tool for personalized medicine: A primer","volume":"7","author":"Kasai","year":"2010","journal-title":"Per. Med."},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/bs.ctdb.2016.07.008","article-title":"Modeling human cancers in Drosophila","volume":"121","author":"Sonoshita","year":"2017","journal-title":"Curr. Top. Dev. Biol."},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-3-030-23629-8_14","article-title":"A Drosophila based cancer drug discovery framework","volume":"1167","author":"Bangi","year":"2019","journal-title":"Adv. Exp. Med. Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/8\/3918\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:26:43Z","timestamp":1760362003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/8\/3918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,10]]},"references-count":330,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["ijms22083918"],"URL":"https:\/\/doi.org\/10.3390\/ijms22083918","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,10]]}}}